4//SEC Filing
HYPERION THERAPEUTICS INC 4
Accession 0001209191-15-040803
CIK 0001386858operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:48 PM ET
Size
13.7 KB
Accession
0001209191-15-040803
Insider Transaction Report
Form 4
Salehizadeh Bijan
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−11,855$545,330→ 0 totalExercise: $4.08Exp: 2021-04-14→ Common Stock (11,855 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−9,800$450,800→ 0 totalExercise: $24.46Exp: 2023-04-14→ Common Stock (9,800 underlying) - Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−2,617$120,382→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−4,105$188,830→ 0 totalExercise: $7.31Exp: 2022-04-15→ Common Stock (4,105 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−4,869$223,974→ 0 totalExercise: $26.97Exp: 2024-05-26→ Common Stock (4,869 underlying)
Footnotes (2)
- [F1]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon Pharma plc (the "Merger").
- [F2]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
Documents
Issuer
HYPERION THERAPEUTICS INC
CIK 0001386858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001386858
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 7:48 PM ET
- Size
- 13.7 KB